Today we’re pleased to announce our investment in a second cultivation and processing facility, allowing us to increase our production capacity in response to significant projected growth in demand for our medical cannabis products in Canada as well as worldwide.
Tilray currently owns and operates one of the world’s most sophisticated federally licensed medical cannabis cultivation and processing facilities, located in Nanaimo, British Columbia. The flagship facility, which opened in 2014, houses a state-of-the-art extraction and research and development centre focused on processing raw cannabis flower into pharmaceutical-grade products, like oils and capsules, in addition to developing new methods of delivery that provide alternatives to smoking.
Our second facility will be located in Enniskillen, Ontario, on a 100-acre property with 13 acres of existing greenhouse space. The property is currently producing peppers for the Enniskillen Pepper Company. Tilray has submitted an application to Health Canada to receive a federal licence for the second facility. In the first phase of the project, the property will house a 10-acre cannabis greenhouse facility containing approximately 40,000 square feet of processing space. The facility is expected to increase Tilray’s current production capacity five-fold by the end of 2018.
Tilray chose Enniskillen because the township is strategically located and has a strong workforce of qualified, skilled agricultural professionals. Tilray plans to hire approximately 50 people to work in operations, production, cultivation and facilities through the end of 2018. Over the next five years, the project is expected to create 200 to 250 full-time jobs in the region.
Tilray was the first company to legally export medical cannabis products from North America to the European Union, Australia, New Zealand and South America. Currently Tilray’s medical cannabis products are available in 7 countries spanning 4 continents. In addition to being the first company to legally export medical cannabis from North America, in 2016 Tilray became the first medical cannabis producer in North America to be GMP-certified in accordance with the European Medicines Agency’s (EMA) Good Manufacturing Practice (GMP) standards. GMP certification is the most rigorous standard that manufacturers of medical products must meet in their production processes and it provides regulators and health-care providers in countries new to medical cannabis with certainty that Tilray products are a safe and smart choice.